About Us

At Pharvis, we strive for a healthier and happier life for every family.

Our History

Our History; Explore our important moments through out our history as we aim to create a happier life for people.

  • 2019
    • 03. Contract exclusive supply agreement of Venostasin Caps with Aenova, Germany.
  • 2018
    • 09. New company building is established in Dogok-dong
    • 05. Selected as one of the highly skilled small and medium sized companies by Ministry of Employment and Labor
    • 03. Selected and received commendation as Exemplary Taxpayer by National Tax Service
    • 03. Obtained permission to manufacture and import Quasi Drugs
    • 02. Obtained permission to import Medical Equipment
    • 02. Contract exclusive supply agreement of I-PEN, Dry eye syndrome diagnostic medical devices.
    • 02. Acquisition of seconod pharmaceutical factory in Ansan city.
  • 2017
    • 12. Contract to furnish sanitary, MomDish, aid to the NongHyup Hanaro
    • 12. Patent registration for film-coated tablets containing water-stabilized alginic acid and CMCNa
    • 10. Selected as Small Hidden Champion by IBK Industrial Bank
    • 08. Acquired a title for small and medium sized companies with innovative technologies
  • 2016
    • 06. Contract exclusive supply agreement of Chanllergen, immunotherapy for mite induced allergic rhinitis & asthma with WOLWO.
  • 2015
    • 08. Contract for technology transfer and signed a Memorandum of Understanding (MOU) on Industry-Academia partnership with Korea University’s and Dongguk University’s Industry-Academia Cooperation groups.
    • 07. Completion of extension construction of the First factory in Ansan
    • 05. Patent registration for oral medicinal properties containing Valsartan
    • 05. All employees went Cambodia and Vietnam for workshop (4night and 6days)
  • 2014
    • 08. Patent registration for pharmacological compound drugs for diabetes treatment
    • 07. Assigned as Venture Business Company from Small and Medium Business Corporation
    • 07. Development of ‘Anti-Ulcer F Tab’, a combination of ranitidine hydrochloride, potassium bismuth cirtrate and succinate hydrate complex peptic ulcer.
    • 04. Patent registration for quantitative analysis method of pharmacology preparation containing Carboxymethylcellulose Alkaline
    • 01. Contract with Ginsana from Switzerland for selling their natural medicines exclusively in Korea
  • 2011
    • 10. Received commendation as Elderly care contributing group
    • 08. Introduced a medicinal preparation from crude drugs (herbal drugs) & diet supplement (obesity treatment)
    • 07. Changed title into Pharvis Korea
    • 04. All employees went Thailand for workshop
  • 2010
    • 11. Patent registration for high quality fermented onion juice and its manufacturing method
    • 05. Established Central Research Institute
  • 2008
    • 06. All employees went Thailand for workshop
  • 2007
    • 11. Signed a MOU contrct with NOUVAG, the Swiss medical device specialist manufacturer
    • 07. Changed title into Pharvisbiotech Korea.
    • 04. Export finished drug to Southeast Asia
  • 2006
    • 08. Community Service Activity (Sponsoring Seocho Senior Welfare Center)
  • 2004
    • 07. Export finished drug to Latin America
  • 2003
    • 07. Changed title into Pharvis Korea.
  • 2002
    • 10. Built Enterprise Resource Planning(ERP) system
  • 2001
    • 11. Export Ginseng based product to Africa
  • 1998
    • 10. Export of ‘Aminocaproic acid’ for injection to Europe
  • 1994
    • 08. Selected as KGMP eligible company by excellent medicine manufacturer
  • 1991
    • 02. Construction of Food GMP Factory in Asan
  • 1990
    • 04. Acquired patent for fermentation method using agricultural products and seaweed
  • 1984
    • 03. Acquired patent for fermentation method using seaweed
  • 1983
    • 09. Established the first health food business division in the domestic pharmaceutical industry
    • 04. Relocated the factory to Ansan city
  • 1980
    • 10. 국내 최초 위염치료제 '플로글루마이드' 원료합성 성공
  • 1976
    • 11. Advance into the pharmaceutical industry with Kyung Hee Pgharmaceutical.
    • 11. Successful synthesis of ‘Aminocaproic acid’, the first hemostatic agent in Korea
TOP